1-15 of 15
Michael Hallek, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role Of Lyn Kinase In The Pathogenesis Of Chronic Lymphocytic Leukemia

Free
Phuong-Hien Nguyen, Nina Reinart, Michael Hallek, M.D. Ph.D.
Journal: Blood
Blood (2013) 122 (21): 668.
https://doi.org/10.1182/blood.V122.21.668.668
Published: 2013
Journal Articles

Overall Survival In Early Stage Chronic Lymphocytic Leukemia Patients With Treatment Indication Due To Disease Progression: Follow-Up Data Of The CLL1 Trial Of The German CLL Study Group (GCLLSG)

Free
Manuela A. Bergmann, MD, Raymonde Busch, PhD, Barbara Eichhorst, MD, Andreas Buehler, MD, Norbert Fischer, MD, Michael J Eckart, MD, Ursula Vehling-Kaiser, MD, Ulrich Jäger, MD, Georg Hopfinger, MD, Clemens Wendtner, MD, Kirsten Fischer, MD, Bertold Emmerich, MD, Hartmut Döhner, MD, Michael Hallek, M.D. Ph.D., Stephan Stilgenbauer, MD
Journal: Blood
Blood (2013) 122 (21): 4127.
https://doi.org/10.1182/blood.V122.21.4127.4127
Published: 2013
Journal Articles

High CD52 mRNA Expression Is An Adverse Prognostic Factor In Fludarabine-Refractory CLL Treated With Alemtuzumab On The Gcllsg CLL2H Trial

Free
Johannes Bloehdorn, MD, Martin Sill, PhD, Christian Langer, MD, Axel Benner, Dipl.Stat., Thorsten Zenz, MD, Andreas Bühler, MD, Raymonde Busch, PhD, Peter Dreger, MD, Ulrich Jäger, MD, Michael Hallek, M.D. Ph.D., Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2013) 122 (21): 1618.
https://doi.org/10.1182/blood.V122.21.1618.1618
Published: 2013
Journal Articles

Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia

Free
TILL M SEILER, MD, Roland Aydin, Tobias Herold, MD, Stefan Holdenrieder, MD, Michael Hallek, M.D. Ph.D., Wolfgang Hiddemann, M.D., Martin Dreyling, Manuela A. Bergmann, MD
Journal: Blood
Blood (2013) 122 (21): 1619.
https://doi.org/10.1182/blood.V122.21.1619.1619
Published: 2013
Journal Articles

Role Of High-Dose Cytarabine and Total Body Irradiation Conditioning before Autologous Stem Cell Transplantation In Mantle Cell Lymphoma - A Comparison Of Nordic MCL2, HOVON 45, and European MCL Younger Trials

Free
Eva Hoster, Christian H Geisler, Jeanette K Doorduijn, Bronno Van der Holt, Jan Walewski, Stephan Stilgenbauer, MD, Vincent Ribrag, Gilles Andre Salles, MD, PhD, Michael Hallek, M.D. Ph.D., Christiane Pott, M.D. Ph.D., Arne Kolstad, Anna Laurell, Riika Räty, Mats Jerkeman, Mars Van't Veer, Hanneke C. Kluin-Nelemans, Wolfram Klapper, Michael Unterhalt, Martin H. Dreyling, Olivier Hermine
Journal: Blood
Blood (2013) 122 (21): 3367.
https://doi.org/10.1182/blood.V122.21.3367.3367
Published: 2013
Journal Articles

Serum Levels Of CD178 (Soluble FasL) Predict Treatment Response and Survival In Chronic Lymphocytic Leukaemia (CLL)

Free
Peter Mollee, Melinda Burgess, Nigel McMillan, Nicholas Saunders, Catherine Cheung, Michael Hallek, M.D. Ph.D., Devinder S Gill
Journal: Blood
Blood (2013) 122 (21): 2866.
https://doi.org/10.1182/blood.V122.21.2866.2866
Published: 2013
Journal Articles

Evaluation Of Myeloablative Therapy Followed By Autologous Stem Cell Transplantation In First Remission In Patients With Advanced Stage Follicular Lymphoma After Initial Immuno-Chemotherapy (R-CHOP) Or Chemotherapy Alone: Analysis Of 940 Patients Treated In Prospective Randomized Trials Of The German Low Grade Lymphoma Study Group (GLSG)

Free
Wolfgang Hiddemann, M.D., Martin H. Dreyling, M.D. Ph.D., Bernd Metzner, M.D., Michael Pfreundschuh, M.D. Ph.D., Martin Wilhelm, M.D. Ph.D., Eva Lengfelder, M.D. Ph.D., Georg Hess, M.D. Ph.D., Michael Hallek, M.D. Ph.D., Norbert Schmitz, M.D. Ph.D., Christiane Pott, M.D. Ph.D., Thomas Fischer, M.D. Ph.D., Roswitha Forstpointner, M.D., Eva Hoster, Ph.D., Michael Unterhalt, M.D. Ph.D.
Journal: Blood
Blood (2013) 122 (21): 419.
https://doi.org/10.1182/blood.V122.21.419.419
Published: 2013
Journal Articles

High-Resolution SNP-Array Profiling of Chronic Lymphocytic Leukemia

Free
Jennifer Edelmann, MD, Karlheinz Holzmann, PhD, W.M. Michael Kühn, MD, Lars Bullinger, MD, Ina Radtke, MD, PhD, Xiaoping Su, PhD, Jing Ma, Ph.D., Dirk Winkler, MD, Andreas Buehler, Michael Hallek, M.D., James R. Downing, MD, Stephan Stilgenbauer, MD, Hartmut Doehner, MD
Journal: Blood
Blood (2010) 116 (21): 50.
https://doi.org/10.1182/blood.V116.21.50.50
Published: 2010
Journal Articles

The Receptor Tyrosine Kinase Inhibitors Vatalanib and Pazopanib Possess Strong Inhibitory Effect on Tumor Growth In a CLL-Like Xenograft Mouse Model

Free
Julian Paesler, Iris Gehrke, Regina Razavi, Simon Jonas Poll-Wolbeck, Michael Hallek, M.D., Karl-Anton Kreuzer
Journal: Blood
Blood (2010) 116 (21): 1393.
https://doi.org/10.1182/blood.V116.21.1393.1393
Published: 2010
Journal Articles

Acute Myeloid Leukemia and Survival on the Intensive Care Unit (ICU) - Biology- and Treatment-Related Determinants of Outcome - An Analysis of the AML-CG

Free
Bernhard Heilmeier, M.D., Johannes Thudium, Matthias Kochanek, M.D., Christoph Schmid, M.D., Joachim Stemmler, M.D., Karl-Anton Kreuzer, Michael Hallek, M.D., G\)nter Schlimok, M.D., Karsten Spiekermann, MD, Wolfgang Hiddemann, MD, Jan Braess, M.D.
Journal: Blood
Blood (2010) 116 (21): 2166.
https://doi.org/10.1182/blood.V116.21.2166.2166
Published: 2010
Journal Articles

Allogeneic Stem Cell Transplantation Can Overcome the Adverse Prognostic Impact of TP53 Mutation In Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3x Trial

Free
Thorsten Zenz, MD, Peter Dreger, MD, PhD, Sascha Dietrich, MD, Sebastian Böttcher, MD, Matthias Ritgen, MD, Dirk Winkler, MD, Andreas Bühler, MD, Donald Bunjes, MD, Dietrich Beelen, MD, Sandra Cohen, MD, FRCPC, Ute Hegenbart, MD, Matthias Zeis, MD, Michael Hallek, M.D., Michael Kneba, MD, PhD, Norbert Schmitz, MD, Hartmut Döhner, MD, Stephan Stilgenbauer, M.D.
Journal: Blood
Blood (2010) 116 (21): 2357.
https://doi.org/10.1182/blood.V116.21.2357.2357
Published: 2010
Journal Articles

Chemoimmuno-Therapy with Fludarabine, Cyclophosphamide and Alemtuzumab in Patients with Relapsed/Refractory CLL: Interim Analysis of the CLL2L Trial of the German CLL Study Group

Free
Thomas Elter, MD, Rojin James, Stephan Stilgenbauer, MD, PhD, Matthias Ritgen, Michael Hallek, M.D., Andreas Engert
Journal: Blood
Blood (2008) 112 (11): 3170.
https://doi.org/10.1182/blood.V112.11.3170.3170
Published: 2008
Journal Articles

Directed Evolution of Immune-Escaping Adeno-Associated Virus Vectors

Free
Stephan Maersch, Anke Huber, Michael Hallek, M.D., Hildegard Buening, Luca Perabo, PhD
Journal: Blood
Blood (2008) 112 (11): 3532.
https://doi.org/10.1182/blood.V112.11.3532.3532
Published: 2008
Journal Articles

Emergence of Dominant T-Cell Populations in Patients with CLL after Allogeneic Transplantation: Mediators for Gvl Effects?

Free
Matthias Ritgen, MD, Monika Brueggemann, MD, PhD, Sebastian Boettcher, MD, Thorsten Raff, MD, Christiane Pott, MD, Michael Hallek, M.D., Michael Kneba, MD, PhD, Peter Dreger, MD
Journal: Blood
Blood (2008) 112 (11): 3503.
https://doi.org/10.1182/blood.V112.11.3503.3503
Published: 2008
Journal Articles

Occurrence of Chromosomal Translocations as Independent Prognostic Factor in Chronic Lymphocytic Leukemia.

Free
Christine Mayr, MD, Cathrine Schulz, M.D., Stephan Stilgenbauer, M.D., Alexander Kröber, M.D., Hartmut Döhner, M.D., Ulrich Jäger, M.D., Birgit Kainz, M.D., Georg Hopfinger, M.D., Rüdiger Hoffmann, M.D., Clemens Wendtner, M.D., Michael Hallek, M.D., Michael R. Speicher, M.D.
Journal: Blood
Blood (2006) 108 (11): 2084.
https://doi.org/10.1182/blood.V108.11.2084.2084
Published: 2006